Table 1.
Patient characteristic | Total | % | |
---|---|---|---|
Age, years | <65 | 23 | 56.10 |
⩾65 | 18 | 43.90 | |
Gender | Male | 26 | 63.41 |
Female | 15 | 36.59 | |
Primary tumor site | Right | 12 | 29.27 |
Left | 14 | 34.15 | |
Rectum | 14 | 34.15 | |
Transverse colon | 1 | 2.44 | |
Extent of metastatic disease | non-LLD | 27 | 65.85 |
LLD | 14 | 34.15 | |
First-line regimen | XELOX | 3 | 7.32 |
FOLFOX | 19 | 46.34 | |
FOLFOX-Bev | 8 | 19.51 | |
FOLFOX-Cet | 5 | 12.20 | |
FOLFIRI | 2 | 4.88 | |
FOLFIRI-Bev | 3 | 7.32 | |
FOLFIRI-Cet | 1 | 2.44 | |
Response rate | PR | 22 | 53.66 |
SD | 11 | 26.83 | |
PD | 8 | 19.51 |